Fulphila

Active Ingredient(s): Pegfilgrastim-jmdb
FDA Approved: * June 4, 2018
Pharm Company: * MYLAN GMBH
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Fulphila Overview

Pegfilgrastim is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim. It serves to stimulate the level of white blood cells (neutrophils).[2] Pegfilgrastim treatment can be used to stimulate bone marrow to produce more neutrophils to fight infection in patients undergoing chemotherapy.[3] Pegfilgrastim has a human half-life of 15 to 80 hours, much longer than the parent filgrastim (3–4 hours).[4][3] In the United States as of 2015 the...

Read more Fulphila Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pegfilgrastim

Recent Fulphila Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Pegfilgrastim-jmdb
  • Injection: 6mg/0.6ml
  • Syringe: 6mg/0.6ml, 6mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Fulphila: (1 result)

Sorted by National Drug Code
  • 67457-833 Fulphila 6 mg/.6ml Subcutaneous Injection by Mylan Institutional LLC

Other drugs which contain Pegfilgrastim-jmdb or a similar ingredient: (3 results)





Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2018 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 19 July 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.